X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with P&G Hygiene - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs P&G HYGIENE - Comparison Results

P&G HYGIENE 
   Change

P&G Hygiene and Healthcare (PGHH) is a 69% subsidiary of the FMCG major - P&G, US. The two-product company is dominating both segments backed by strong brands, namely 'Vicks' in the anti-cold segment and 'Whisper' in feminine care segment (40% market... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES P&G HYGIENE AMAR REMEDIES/
P&G HYGIENE
 
P/E (TTM) x -0.5 57.4 - View Chart
P/BV x 0.1 17.6 0.3% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   P&G HYGIENE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
P&G HYGIENE
Jun-16
AMAR REMEDIES/
P&G HYGIENE
5-Yr Chart
Click to enlarge
High Rs1646,982 2.3%   
Low Rs865,171 1.7%   
Sales per share (Unadj.) Rs261.6765.4 34.2%  
Earnings per share (Unadj.) Rs17.4130.4 13.3%  
Cash flow per share (Unadj.) Rs22.3146.3 15.2%  
Dividends per share (Unadj.) Rs036.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.7465.6 21.6%  
Shares outstanding (eoy) m26.1632.46 80.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.9 6.0%   
Avg P/E ratio x7.246.6 15.4%  
P/CF ratio (eoy) x5.641.5 13.5%  
Price / Book Value ratio x1.213.1 9.5%  
Dividend payout %027.6 0.0%   
Avg Mkt Cap Rs m3,270197,237 1.7%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m1631,186 13.7%   
Avg. sales/employee Rs ThNM70,178.8-  
Avg. wages/employee Rs ThNM3,349.2-  
Avg. net profit/employee Rs ThNM11,954.2-  
INCOME DATA
Net Sales Rs m6,84424,843 27.5%  
Other income Rs m21876 2.4%   
Total revenues Rs m6,86525,719 26.7%   
Gross profit Rs m1,1316,046 18.7%  
Depreciation Rs m128517 24.8%   
Interest Rs m39840 990.0%   
Profit before tax Rs m6266,365 9.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1212,134 5.7%   
Profit after tax Rs m4554,232 10.8%  
Gross profit margin %16.524.3 67.9%  
Effective tax rate %19.333.5 57.7%   
Net profit margin %6.617.0 39.0%  
BALANCE SHEET DATA
Current assets Rs m4,90416,336 30.0%   
Current liabilities Rs m3,5816,498 55.1%   
Net working cap to sales %19.339.6 48.8%  
Current ratio x1.42.5 54.5%  
Inventory Days Days12419 663.5%  
Debtors Days Days10022 455.6%  
Net fixed assets Rs m1,6893,516 48.0%   
Share capital Rs m262325 80.7%   
"Free" reserves Rs m2,35814,788 15.9%   
Net worth Rs m2,63515,112 17.4%   
Long term debt Rs m5070-   
Total assets Rs m6,86221,646 31.7%  
Interest coverage x2.6159.3 1.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.1 86.9%   
Return on assets %12.419.7 63.0%  
Return on equity %17.328.0 61.7%  
Return on capital %31.042.4 73.1%  
Exports to sales %4.00.4 1,122.3%   
Imports to sales %09.6 0.0%   
Exports (fob) Rs m27388 309.2%   
Imports (cif) Rs mNA2,394 0.0%   
Fx inflow Rs m27389 305.7%   
Fx outflow Rs m24,911 0.0%   
Net fx Rs m271-4,822 -5.6%   
CASH FLOW
From Operations Rs m-3133,533 -8.8%  
From Investments Rs m-4892,245 -21.8%  
From Financial Activity Rs m769-1,217 -63.1%  
Net Cashflow Rs m-334,561 -0.7%  

Share Holding

Indian Promoters % 25.5 1.9 1,342.1%  
Foreign collaborators % 0.0 68.7 -  
Indian inst/Mut Fund % 9.2 12.3 74.8%  
FIIs % 0.0 2.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.7 444.2%  
Shareholders   13,061 22,617 57.7%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   KARUTURI GLOBAL  GILLETTE INDIA  GODREJ INDUSTRIES  GODREJ CONSUMER  RELAXO FOOTWEARS  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Plummets 390 Points; Infosys Continues to Fall(01:30 pm)

After opening the day on a negative note, the share markets in India continued to witness selling pressure as Infosys cracked after Vishal Sikka's resignation as MD & CEO.

Related Views on News

P&G: Strong Core Growth (Quarterly Results Update - Detailed)

Dec 9, 2016

Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

P&G: Strong Core Performance (Quarterly Results Update - Detailed)

Oct 5, 2016

Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS